<qa>  What is the potential study that evaluates the ability of 89Zr-DfThis is a prospective, multicenter, open-label, non-randomized study evaluating the ability of 89Zr-Df-IAb2M to detect local, regional and metastatic prostate cancer confirmed by pathology. 